Utility of a TDM-Guided Expert Clinical Pharmacological Advice Program for Optimizing the Use of Novel Beta-Lactam/Beta-Lactamase Inhibitor Combinations and Cefiderocol in a Tertiary University Hospital: An Interim Analysis
A dedicated TDM-guided ECPA program may be helpful for optimizing the use of novel agents in settings with a high prevalence of multidrug-resistant pathogens.
Authors
- Matteo Rinaldi (ORCID: https://orcid.org/0000-0002-3568-5973)
- Simone Ambretti (ORCID: https://orcid.org/0000-0002-8358-339X)
- Milo Gatti (ORCID: https://orcid.org/0000-0003-3018-3779)
- Pier Giorgio Cojutti (ORCID: https://orcid.org/0000-0001-7135-4410)
- Maddalena Giannella (ORCID: https://orcid.org/0000-0001-8273-7601)
- Federico Pea (ORCID: https://orcid.org/0000-0002-6966-7167)
- Pierluigi Viale
Institutions
- Azienda USL di Bologna (IT)
- University of Bologna (IT)
Publication Details
- Journal
- Therapeutic Drug Monitoring
- Published
- 2025-05-02
- DOI
- https://doi.org/10.1097/ftd.0000000000001334
- Citations
- 5
- Primary Topic
- Antibiotics Pharmacokinetics and Efficacy
- Type
- article
- Field-Weighted Citation Impact
- 6.97